The global intraocular lens market is expected to grow at a CAGR of 4% over 2021-2027. An intraocular lens (IOL) is an implantable medical device used to correct vision. The main factors driving the intraocular lenses market are increasing eye problems, increasing cases of cataracts in diabetics, and increasing adoption of advanced premium IOLs. Many people over the age of 60 are chronic and affected by several types of eye problems that require eye correction. Because of these scenarios, the growth of IOLs increases with demand, providing doctors with more accurate solutions and more options for certain diseases. Additionally, the presence of a reimbursement policy for essential eye surgery and a clear regulatory framework is fueling the market’s growth.
A full report of Intraocular Lens Market available at https://www.orionmarketreports.com/intraocular-lens-market/26742/
The key companies operating in the intraocular lens market are Alcon, Inc. (division of Novartis AG), Johnson & Johnson, Valeant, Carl Zeiss Meditec AG, Rayner, EyeKon Medical, Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical, and HOYA GROUP. The other players operating in the market include PhysIOL s.a., Calhoun Vision Center, and Oculentis GmBH.
Intraocular Lens Market: Segmentation
By Type
• Monofocal Intraocular Lens
• Premium Intraocular Lens
By Material
• Polymethylmethacrylate (PMMA)
• Silicone
• Hydrophobic Acrylic
By End User
• Hospitals
• Ambulatory Surgery Centers
• Ophthalmology Clinics
• Eye Research Institutes
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
